We have cloned, sequenced, and characterized the RNA expression properties of a ®sh CDKN2 gene from Xiphophorus helleri and X. maculatus. This gene, termed CDKN2X, shows a high degree of amino acid sequence similarity to members of the mammalian CDKN2 gene family, which includes the tumor suppressor loci CDKN2A (P16) and CDKN2B (P15). Comparative sequence analysis suggests that ®sh CDKN2X is similarly related to all four mammalian gene family members, and may represent a descendant of an ancestral prototypic CDKN2 gene. CDKN2X was mapped to a region on autosomal Xiphophorus linkage group V (LG V) known to contain the DIFF gene that acts as a tumor suppressor of melanoma formation in X. helleri/X. maculatus backcross hybrids. Thus, CDKN2X may be a candidate for the tumor suppressor DIFF gene. Here we have sequenced CDKN2X in both Xiphophorus species and have characterized its expression in normal and melanotic tissues within control and backcross hybrid ®sh. A simultaneous expressional analysis of the Xmrk-2 tyrosine kinase receptor gene, which is strongly implicated in melanomagenesis in this system, was also performed. RT ± PCR analyses revealed that both genes were highly expressed in melanomas. For CDKN2X, this result contrasts numerous ®ndings in human tumors including human melanoma in which either CDKN2A (P16) deactivation or LOH was observed.
Introduction
The human CDKN2A gene, also known as P16, INK4A and MTS1 was initially cloned using the yeast two-hybrid protein interaction screen, exploiting the direct binding of p16 CDKN2A with cyclin dependent kinase 4 (CDK4; Serrano et al., 1993) . CDKN2A was later independently cloned by two other groups that had localized tumor suppressor eects to human chromosomal region 9p21; this region had been known to undergo chromosomal translocations, inversions, and heterozygous and homozygous deletions in cell lines derived from many dierent tumor types (Kamb et al., 1994; Nobori et al., 1994) . Results of numerous other laboratories con®rmed that CDKN2A can be homozygously or heterozygously deleted, mutated, or transcriptionally repressed through methylation of cytosine bases within the 5' CpG island in a variety of human neoplasms (see Dracopoli and Fountain, 1996; Gonzalez-Zulueta et al., 1995; Herman et al., 1995; Pollock et al., 1996; Ruas and Peters, 1998 for review) .
Currently, the mammalian CDKN2 gene family also includes three other members, CDKN2B (also known as P15, INK4B, MTS2), CDKN2C (P18) and CDKN2D (P19) (Chan et al., 1995; Guan et al., 1994; Hannon and Beach, 1994; Hirai et al., 1995; Kamb et al., 1994) . All gene family members are composed of four or ®ve ankyrin repeats, and bind to CDK4 and CDK6. Extensive research has established CDKN2B as a bona®de tumor suppressor candidate, perhaps implicated in the development of leukemia and gliomas (Herman et al., 1995; Jen et al., 1994; Linardopoulos et al., 1995; Robinson et al., 1990) , while tumor suppressor functions of CDKN2C and  CDKN2D have not yet been demonstrated.
The ®sh genus Xiphophorus has long been established as a model organism for the study of melanoma formation (Anders, 1991; Gordon, 1931; Haussler, 1928; Kosswig, 1927; Schartl, 1995; Vielkind et al., 1989) . Melanomas occur in backcross ®sh as the result of speci®c hybrid matings, thus minimizing potential environmental eects in genetic studies. Alternatively, hybrids can be created which are generally more susceptible than parental ®sh to melanoma induction by chemical compounds (such as N-methyl-N-nitrosourea (MNU)), or radiation (X-ray, UV; Nairn et al., 1996a,b; Schwab et al., 1978; Setlow et al., 1989 Setlow et al., , 1993 .
A`two-gene' spontaneous melanoma model (which does not exclude the involvement of other loci) has been developed to explain pigment pattern enhancement and melanoma formation in hybrid ®sh constructed between the platy®sh X. maculatus and the swordtail X. helleri (Anders, 1967 (Anders, , 1991 Schartl, 1995; Vielkind et al., 1989) . This cross has been historically named`Gordon-Kosswig' in honor of two pioneering investigators (Anders, 1991) . When F 1 hybrids are made between the swordtail X. helleri and the platy®sh X. maculatus, the spotted dorsal (Sd) macromelanophore pigment pattern, derived from the latter species, is phenotypically enhanced. Further enhancement of Sd occurs in backcross hybrids (to X. helleri), and nodular melanomas form in many of these latter animals. Speci®cally implicated is a sex-linked oncogene related to human epidermal growth factor receptor (called Xmrk, x-erb-B*a or Xmrk-2; Anders, 1967 Anders, , 1991 Schartl, 1995; Vielkind et al., 1989; Woolcock et al., 1994; Zechel et al., 1988) , and an uncloned autosomal tumor suppressor locus, termed DIFF (Siciliano et al., 1976; Vielkind, 1976) . Xmrk-2 has been mapped to the sex-chromosomal region harboring the macromelanophore locus (Schartl, 1990; Weis and Schartl, 1998) . Both the macromelanophore locus and Xmrk-2 are considered`accessory' loci, as individual ®sh within a population can be found without either locus (Schartl, 1990; Weis and Schartl, 1998; Wittbrodt et al., 1989; Woolcock et al., 1994; Zechel et al., 1989) . A structurally closely related gene known as Xmrk-1 also resides on the sex chromosomes, but its expression is not correlated to melanomagenesis; instead, it is expressed during embryogenesis, and in adult tissues as well (Adam et al., 1991; Woolcock et al., 1994; Zechel et al., 1992a,b) . Further work showed that the two Xmrk genes have totally divergent promoters (Adam et al., 1993; Baudler et al., 1997; Woolcock et al., 1994) .
The DIFF locus was previously mapped to Xiphophorus linkage group V (LG V; Ahuja et al., 1980; Morizot and Siciliano, 1983; Siciliano et al., 1976) . According to one genetic model, it is proposed that backcross hybrids (to X. helleri) not inheriting a X. maculatus DIFF gene copy are most prone to developing melanomas (Anders, 1967 (Anders, , 1991 Schartl, 1995; Vielkind et al., 1989) . Other genetic crosses have recently been used that similarly implicate the DIFF tumor suppressor locus (Nairn et al., 1996a,b) . One such cross substitutes the X. maculatus strain Jp 163 B and the X-linked spot-sided (Sp) pigment pattern gene for strain Jp 163 A (with the X-linked Sd pigment pattern gene). A similar phenomenon of phenotypic enhancement and melanoma formation is evident in derived backcross hybrids to X. helleri in this case as well. This model also has proven to be amenable to UV induction of melanomas (Nairn et al., 1996a,b; Setlow et al., 1989 Setlow et al., , 1993 . Genetic mapping within the Xiphophorus LG V region using combined isozyme, RFLP, and AP-PCR/RAPD protocols has been initiated in order to clone the DIFF tumor suppressor gene (Kazianis et al., 1996 (Kazianis et al., , 1998b Morizot et al., 1991) . We have also cloned selected tumor suppressor gene homologs from Xiphophorus, particularly those that are involved in the suppression of human neoplastic disease. Towards this goal, Xiphophorus TP53 was partially cloned, but proved to map to LG XIV, independent of the linkage group harboring DIFF (Kazianis et al., 1998a; Nairn et al., 1995) . Recently, we partially cloned a ®sh member of the CDKN2 gene family and mapped this gene to Xiphophorus LG V (Nairn et al., 1996b) , within the genomic region shown to include the DIFF melanoma tumor suppressor gene (Kazianis et al., 1998b) . In addition, highly signi®cant associations of CDKN2 homozygosity (for X. helleri alleles) were established with melanotic tumor formation (Kazianis et al., 1998b; Nairn et al., 1996b) . These results collectively imply that the ®sh CDKN2 gene (designated CDKN2X;`X' indicating Xiphophorus) is a candidate for the classically de®ned DIFF tumor suppressor gene, and that CDKN2 genes could be acting as melanoma suppressor genes in both Xiphophorus and human.
It has been hypothesized that expression of the DIFF tumor suppressor gene could be inversely correlated with transcriptional levels of the Xmrk-2 oncogene, with tumors hypothetically showing little or no DIFF expression, and extremely elevated Xmrk-2 transcript levels (Schartl, 1995; Schartl et al., 1997) . Thus, any candidate gene for the DIFF locus, such as CDKN2X, would have to be characterized with respect to its structure and expression to address such an hypothesis.
In this report, we present the entire genomic and coding sequences of the CDKN2X locus from both X. helleri and X. maculatus. To examine the gene's role in melanoma formation we have assayed its RNA transcriptional expression in normal and melanomatous tissues in hybrid ®sh, and assessed expression in normal tissues of parental ®sh. To test the hypothesis of inversely related expression between CDKN2X and Xmrk-2, RNA expression of Xmrk-2 was determined as well.
Results

CDKN2X cloning and structural organization
Using Touchdown-PCR (Don et al., 1991) , with primers designed from published mammalian CDKN2 gene family sequences, a 130 bp amplimer derived from X. maculatus genomic DNA was initially obtained (Nairn et al., 1996b) . Computer translation of the DNA sequence revealed it was probably representative of a ®sh CDKN2 gene family member. DNA sequence analysis of genomic fragments from conventional (Mullis et al., 1986) and inverse PCR (Ochman et al., 1988) ampli®cation as well as of two genomic library lphage clones allowed the establishment of a 6128 bp contiguous sequence for X. maculatus (strain Jp 163 A; Genbank U69273) and a 3427 bp region from X. helleri (Rio Sarabia strain; AF132500). 5' and 3' RACE analyses (Frohman et al., 1988) were conducted for both species, enabling an assignment of transcript start sites and sizes, exon/intron boundaries, functional polyadenylation consensus sequences, and the position of polyA tails. Based on DNA sequencing of four 5' RACE, ®ve 3' RACE clones, full length RT ± PCR ampli®cation and comparison to genomic sequences, it was revealed that the gene sequence contains only one intron (see Figure 1 ) which is conserved in position between X. helleri and X. maculatus. CDKN2X transcript sizes are 1375 bp for X. helleri and 1207 bp for X. maculatus, although the former species apparently utilizes two distinct polyadenylation consensus sequences, giving rise to transcripts diering in size by *180 bases. Only one of the three 3' RACE products showed the use of the second polyadenylation consensus sequence in X. helleri. The full mRNA sequences from both species, along with the respective translated aa sequences have been submitted to Genbank (U69273, AF132500).
Comparative sequence of upstream areas
Analysis of the 5'¯ank/presumptive promoter areas of X. helleri and X. maculatus revealed that while alignment was unambiguously performed (using Clustal W version 1.6; Thompson et al., 1994) and indicated sequence homology in general, several gross dierences and multiple single-nucleotide substitutions were delineated. Figure 2 depicts the nucleotide alignment of these upstream areas outlining differences, and showing the transcriptional start sites determined by 5' RACE. In both X. helleri and X. maculatus, two 5' RACE experiments were performed using gill RNAs as starting material. As shown in Figure 2 , it is apparent that X. helleri uses a transcriptional start site 28 bp downstream of the one shown for X. maculatus. Computer analysis (using MatInspector software; Quandt et al., 1995) of the areas upstream (100 bp 5' or less) of the experimentally derived transcriptional start sites showed lack of consensus`TATA' sequences. Computer analysis also revealed numerous areas of sequence conservation between the two ®sh taxa, matching published consensus sequences for Ap1, Oct1, cMYB, MYOD and USF transcription factors (positions not shown ± references provided within MatInspector documentation; Quandt et al., 1995) . Both taxa also share a 9 bp consensus sequence that is present in the tyrosinase promoters of human, mouse, Japanese quail (Coturnix coturnix) and turtle (Trionyx sinensis, see Figure 2 ; Bentley et al., 1994) .
The most obvious gross dierence in upstream sequence between the two taxa is a near-perfect GT repeat area which constitutes 160 bp in X. maculatus (GT 80 ), while only occupying 20 bp (GT 10 ) in the swordtail. This area is only 264 bp upstream of the experimentally determined start of transcription in X. maculatus. Two other sequences (38 and 66 bp) just upstream of the X. maculatus GT repeat area are present in this species but absent in X. helleri. In contrast, a 20 bp region 32 bp upstream of the start of Figure 1 Graphical depiction of position, origin and nomenclature of all genomic clones involved in this study. Shaded areas are indicative of exonic regions. A 1000 bp scale is provided in the lower right Figure 2 Nucleotide alignment between sequences just upstream of the start of translation (start codon is outlined in black) between X. helleri and X. maculatus. Boxed areas delineate nucleotide dierences. Arrows (downward for X. helleri, upward for X. maculatus) indicate the start of transcription (as determined by 5' RACE). Two regions similar to that of a 9 bp sequence conserved in tyrosinase promoters (Bentley et al., 1994) are shown in bold. The location of a GC-box is underlined transcription is present in X. helleri and not in X. maculatus. A single GC box consensus is present in X. helleri within the 5' untranslated region (UTR; Figure  2 ). Sequences derived from X. maculatus at this region reveal a single bp substitution (A instead of C), and such a dierence reduces consensus matching scores radically ( Figure 2 ). These results collectively imply that the two species show numerous 5'¯ank/promoter sequence dierences with possibly important functional consequences regarding the transcriptional control of each. Future research with respect to CDKN2X promoter delineation, structure and function could be an important avenue of further investigation.
Comparative structure of known CDKN2 genes Xiphophorus CDKN2X codes for a 124 aa protein of a predicted 13.0 kDa mass (for both studied species). The polypeptide is comprised of four nearly complete ankyrin repeats (Michaely and Bennett, 1992) , similar to mammalian p15 polypeptides within this region contain arginines which are conservative dierences with respect to X. maculatus' lysine. We should note that ®sh p13 CDKN2X partial sequence originally published (Nairn et al., 1996b) had one erroneous aa in relationship to the sequences we present here. This inaccuracy stems from a sequencing compression that we believe is now solved after employment of a dITP dideoxy terminator sequencing kit (Amersham, NJ, USA).
The position of the ®sh CDKN2X intron is conserved with respect to interruption of exons 1 and 2 within human/mouse CDKN2A, -B and -C loci (Guan et al., 1994; Jiang et al., 1995 , the genomic organization of CDKN2D has not been published at this time). The CDKN2A locus of both human and mouse is unique in that it encodes, in addition to p16 CDKN2A , p14
ARF in humans and p19 ARF in mice. This is accomplished through the use of alternate ®rst exons, termed E1a (for p16 CDKN2A ) and E1b (for p14 ARF or p19 ARF ) and a sharing of second and third exons, although the phasing of the coding region is shifted to eectively create two completely distinct proteins Quelle et al., 1995; Stone et al., 1995) . A 5' RACE experiment using primers within the second exon of Xiphophorus CDKN2X failed to amplify products representative of an ARF (alternate reading frame) polypeptide. In addition, computer translation of the second exon in the two alternate frames revealed the presence of stop codons that would prematurely terminate formation of polypeptides equivalent to mammalian ARF counterparts.
Recently, several reports have addressed the structural properties of CDKN2 proteins (Kalus et al., 1997; Luh et al., 1997; Venkataramani et al., 1998) . These studies are unanimously in agreement that ankyrin structural repeats comprising CDKN2 proteins create b-strand, a-helix/b-turn/a-helix extended bstrand motifs, and that these motifs associate with each other through b-sheet and helical bundle interactions. Numerous residues likely to be important for such structure and predicted to be conserved within CDKN2 proteins were also outlined in these studies; these residues are conserved in the ®sh p13
CDKN2X
. As an example, consider the b-turns, which consistently show central glycine residues: these are conserved among known CDKN2 proteins, including Xiphophorus p13 CDKN2X ( Figure 3 ).
Evolutionary relationships between CDKN2 gene family members
Several standard methods of phylogenetic reconstruction were employed in an attempt to de®ne the phylogenetic relationship of ®sh CDKN2X to mammalian CDKN2 gene gamily members. These results are partially presented as a`Dayho-Pam' distance matrix (Table 1 ; Dayho and Orcutt, 1979) and maximum parsimony bootstrap tree ( Figure 3 ; Maddison and Maddison, 1992) . Examination of the distance matrix presented in Table 1 (1705730, 2493567) . Darkened areas indicate conservation (identity and similarity) between X. helleri and taxa listed below (produced with the program DNAdraw; . Ankyrin repeats I ± V are demarcated below the aa sequences. Downward-facing arrows delineate the ®ve glycines within p18 CDKN2C and p19 CDKN2D that are involved in the formation of b-turns (Kalus et al., 1997; Luh et al., 1997; Venkataramani et al., 1998) . Numbering at right refers to Xiphophorus aa positions polypeptides suggest that they are most similar to each other. It is noteworthy that they in turn, are more similar to the ®sh p13 CDKN2X polypeptide than to p18 CDKN2C and p19 CDKN2D (see Table 1 ). Analysis of the tree derived from maximum parsimony (Figure 4 ) clearly portrays the CDKN2C (P18) and CDKN2D (P19) mammalian genes as being monophyletic, with unambiguous orthology between human and rodent counterparts. Availability of the ®sh sequences also assists in establishing the phylogenetic relationship between mammalian CDKN2A and -B loci. Bootstrap values presented in Figure 4 indicate that while monophyly of the p16 CDKN2A and p15 CDKN2B group is robustly supported (100%), human p16 CDKN2A is distinctly more similar to p15 CDKN2B orthologs (than to mouse or rat p16 CDKN2A ; see Table 1 and Figure 4 ). This result supports the hypothesis that human p16 CDKN2A has undergone a gene conversion event at the 3' end of intron 1 and in the 5' end of the second exon, where *310 bp of sequence from the tightly linked p15 CDKN2B locus have replaced ancestral sequences . Presumably, this event occurred through a homologous recombination event in a human ancestral taxon and distinct from the rodent lineage.
RNA expression characteristics of CDKN2X and Xmrk-2
The RNA expression characteristics of CDKN2X and the Xmrk-2 oncogene were determined in normal tissues from X. helleri and X. maculatus as well as from normal and melanized tissues from their ®rst generation backcross hybrids (BC 1 ; to X. helleri). Since numerous normal ®sh tissues harbor melanocytes and melanophores, it is noted that`melanized' tissues within this manuscript refers to dissected material that is phenotypically laden with such melanincontaining cells. For example, dissected`melanized' skin is black in contrast to the olive-gray`nonmelanized' normal tissue counterpart.
CDKN2X RNA expression was determined using à relative RT ± PCR' strategy, simultaneously quantifying CDKN2X vs 18S rRNA transcripts within numerous tissues (Ambion, TX, USA). Xmrk-2 expression was quantitated using a competitive RT ± PCR protocol which relies on co-ampli®cation of the endogenous Xmrk-1 gene and subsequent quantitation using phosphorimaging methods (see Woolcock et al., 1994 and Materials and methods section).
Expression within control tissues and BC 1 hybrids
Relative CDKN2X RNA expression (in relationship to endogenous 18S rRNA levels) was assessed in tissues dissected from X. helleri and X. maculatus. Transcripts were readily detected in all tissues tested, although kidney, gill, eye and caudal ®n displayed the highest levels while liver, heart and muscle (derived from the caudal peduncle) showed the lowest (in both taxa; data not shown). The RNA expression characteristics of Xmrk-2 have been previously described, showing detectable expression in gill, eyes, skin and ®ns derived from X. maculatus ®sh assayed (Woolcock et al., 1994) .
RNA expression characteristics of CDKN2X and Xmrk-2 were assayed in BC 1 hybrids (n=33) derived from the (X. helleri6(X. maculatus Jp 163 B6X. helleri) cross involving the Sp pigment pattern. (Dayho and Orcutt, 1979; Felsenstein, 1989) . Larger numbers indicate greater genetic distance. Accession numbers of mammalian CDKN2 sequences are as in Figure 2 Characterization of a fish CDKN2 gene S Kazianis et al
Backcross hybrids inheriting the Sp pigment pattern exhibit a range of phenotypes from those showing extreme cutaneous melanization/melanoma formation, to ®sh that contain small patches of melanized areas on their bodies. Thus, it was possible to extract tissues from a variety of animals and tissue types, and to compare RNA expression characteristics in melanized and non-melanized tissues from the same individual ®sh. Analysis of Xmrk-2 RNA expression is presented in Figure 5 . Although normal tissues within BC 1 ®sh exhibit relatively low expression, melanized tissues and exophytic melanomas show pronounced increases in expression. Melanized tail-®n and skin show signi®cant increases in Xmrk-2 transcript over their non-melanized counterparts (using a 2 tailed t-test; P=0.003 and P=0.017, respectively). While melanized muscle shows a slight increase over non-melanized muscle, this dierence is not signi®cant (P=0.231) but could be explained by the huge excess of muscle in such dissected`melanized' tissue (histological evaluation, data not shown). Exophytic melanomas especially show marked overexpression of the Xmrk-2 oncogene in relationship to normal tissues derived from the same animals. For example, melanomas show a highly signi®cant (4sixfold) greater expression than nonmelanized skin (P=0.0009). These results are consistent with previous studies which described marked overexpression of the Xmrk-2 oncogene in melanomas derived from other distinct Xiphophorus crosses (Adam et al., 1991; Wittbrodt et al., 1989; Woolcock et al., 1994; Zechel et al., 1992b) . The data presented here are also consistent with the hypothesis (Woolcock et al., 1994) that Xmrk-2 could be implicated in the formation of the Xiphophorus pigment patterns themselves, since it is expressed at signi®cantly higher levels in melanized tissues as opposed to non-melanized controls.
CDKN2X expression levels were also quantitated, and the results of the relative RT ± PCR technique are presented in Figure 6 . Expression within brain, eye, gill, liver and muscle was easily detectable and associated with the general expression pattern in parental (X. helleri/X. maculatus) controls. Melanomas show a highly signi®cant (4sevenfold) higher expression in comparison to non-melanized skin (P=0.00002) and signi®cantly higher expression than melanized skin as well (P=0.033). Melanized skin and tail-®n also showed somewhat higher CDKN2X expression than their non-melanized counterparts derived from the same individuals, although this is statistically significant only for skin (P=0.025).
Allele-speci®c CDKN2X RT ± PCR
Recently, it was shown that 83.7% of the melanomabearing (X. helleri6X. maculatus Jp 163 B6X. helleri ) BC 1 ®sh (all of these harbor the Sp pigment pattern and the associated Xmrk-2 oncogene) were homozygotes for X. helleri CDKN2X (Kazianis et al., 1998b) . Thus, we were particularly interested in examining the expression of CDKN2X in exceptional heterozygous (i.e. with one CDKN2X allele from X. maculatus and one from X. helleri) BC 1 hybrids that developed melanoma. Using the relative RT ± PCR assay, we compared the overall CDKN2X expression levels between homozygous and heterozygous animals within 18 melanomas (14 homozygote, four heterozygote individuals). Within each group, CDKN2X proved to be strongly expressed and there were no signi®cant dierences between the groups (a mean of 0.99 homozygotes vs 0.94 for heterozygotes; t-test P=0.86). This comparison was also performed for eye (n=12 total; P=0.28), gill (n=22; P=0.98), melanized skin (n=15; P=0.18), and non-melanized skin (n=7; P=0.24) with no signi®cant dierences between the groups.
To examine CDKN2X allele-speci®c expression in tissue from heterozygous BC 1 hybrids, an RT ± PCR/ restriction endonuclease assay was developed. After Figure 5 (a) Example of a phosphorimage derived from Xmrk-1/ Xmrk-2 RT ± PCR ampli®cation followed by Southern hybridization and subsequent quantitation. Samples 7141-20 and 7038c-74 represent two BC 1 hybrid ®sh.`Mel.' is an abbreviation for melanized' while`Non-mel.' represents tissue which was grossly free of melanized cells. (b) Xmrk-2 RNA expression in normal, melanotic and exophytic melanoma tissues derived from backcross hybrid Xiphophorus. Expression was quantitated by determining the phosphorimaged ratio of Xmrk-2 oncogene vs. the endogenous Xmrk-1 proto-oncogene amplimers (Woolcock et al., 1994 and Materials and methods) . The Y-axis represents the mean ratio of Xmrk-2/Xmrk-1 transcript level while the X-axis represents the tissue type and number of animals analysed. Error bars are indicative of the standard error Characterization of a fish CDKN2 gene S Kazianis et al quantitation of ampli®ed/restricted products, this assay generated ratios of X. maculatus/X. helleri CDKN2X expression. We examined a total of ten heterozygous hybrid ®sh involving nine tissue types, and these data are presented in Table 2 . The data clearly show that in 23 of 25 cases the X. maculatus CDKN2X allele is expressed at higher level. This phenomenon was especially pronounced in melanoma (Ratio=11.16) and melanized skin (Ratio=6.43), although testing in some other tissues was obviously not extensive. The two exceptional tissues were non-melanized tail-®ns which showed a slightly higher X. helleri CDKN2X allelic expression. It should be noted that dierences in expression between parental alleles in hybrid Xiphophorus represents an exceptional situation, as examination of *80 isozyme loci comprising hundreds of alleles within many hybrid types (Morizot et al., 1991 (Morizot et al., , 1998 Morizot and Siciliano, 1982; Scholl and Anders, 1973a) has revealed only two documented situations where one parental allele is preferentially expressed (Herrera, 1979; Scholl and Anders, 1973b) . In summary, while the X. maculatus CDKN2X allele is expressed at signi®cantly higher levels than X. helleri alleles within melanomas derived from heterozygote BC 1 hybrids, such tumors derived from homozygote ®sh (with two X. helleri alleles) also showed strong CDKN2X expression. Such results imply that there may be complicated and compensatory underlying transcriptional regulation worthy of further investigation.
Discussion
We have cloned, sequenced, and characterized the RNA expression characteristics of a Xiphophorus CDKN2 gene from X. helleri and X. maculatus. The ®sh polypeptide, which encodes a 13 kDa polypeptide termed p13 CDKN2X , is the ®rst gene family member cloned from a non-mammalian taxon. It shows a high degree of aa sequence similarity to all four members of the mammalian CDKN2 gene family. The position of the ®rst intron in Xiphophorus CDKN2X is conserved in mammalian CDKN2A, -B and -C loci. All CDKN2 proteins are comprised of between 4 and 5 ankyrin repeats and ®sh p13 CDKN2X is most like mammalian p15 CDKN2B in that is comprises nearly four repeats. Conservation in upstream residues outside these ankyrin repeats is much lower; for example, human and mouse p16 CDKN2A polypeptides are distinctly dierent in this area (Figure 3) .
Since ®sh CDKN2X seems to be nearly equally related to all four mammalian gene family members, it is possible that the Xiphophorus gene may represent a descendant of a common ancestor which gave rise Mel.' is an abbreviation for`melanized' while`Non-mel.' represents tissue which was grossly free of melanized cells. 1 kb ladder is from Gibco ± BRL (MD, USA). (b) Relative CDKN2X RNA expression in normal tissues derived from backcross hybrid Xiphophorus. Expression was quantitated by comparing the densitometric ratio of CDKN2X vs 18S rRNA in a relative protocol described in the Materials and methods section. The Yaxis represents the mean ratio of CDKN2X/18s rRNA transcript level while the X-axis represents the tissue type and number of animals analysed. Error bars are indicative of the standard error (presumably through gene duplication events and further evolution) to the four identi®ed mammalian gene family members. If this idea is true, the data also clearly support monophyly of the mammalian CDKN2A and CDKN2B group, and it can be hypothesized that they arose from a later gene duplication event, perhaps occurring exclusively within the mammalian lineage. In addition, it is possible that ®sh may harbor only one CDKN2 gene and that duplication in mammals may have created important redundancy and/or divergence of tissue-speci®c expression. It has already been well established, for example, that while human p15 CDKN2B and p16 CDKN2A both bind to CDK4/CDK6, they are expressed dierently in various tissues, and their respective promoters are divergent in sequence and responsiveness to TGFb and pRB levels (Hara et al., 1996; Li et al., 1995; Lukas et al., 1995) . Undoubtedly, further attempts at cloning CDKN2 gene family members from Xiphophorus and/or taxonomic groups and delineation of their transcriptional regulation should provide more insight regarding the divergence of gene family members.
CDKN2X maps to a region known to harbor a locus referred to as the DIFF tumor suppressor gene whose loss is believed to be instrumental in melanoma formation in BC hybrids (Kazianis et al., 1998b; Nairn et al., 1996b) . The strong correlation of melanoma formation in 83.7% of Sp-bearing BC 1 hybrids with replacement of the X. maculatus CDKN2X alleles by those from X. helleri also supports the candidacy of CDKN2X for being DIFF. Genetic predisposition of BC 1 hybrid ®sh towards the development of melanoma could theoretically be explained if the two species' CDKN2X sequences either dier signi®cantly within the protein-coding regions, or alternatively, the gene is somatically deleted or regulated/expressed in a dierent manner. Since the aa sequence of the p13 CDKN2X polypeptides from X. helleri and X. maculatus shows only one nonconservative change, it is unlikely that coding region dierences could account for susceptibility to melanoma formation. Examination of RNA expression in melanomas derived from BC 1 ®sh reveals distinctly elevated expression of CDKN2X. Such expression in diseased tissues excludes somatic deletion phenomena but does not rule out the possibility of dierential methylation patterning or somatic mutation as being implicated in melanomagenesis. Preliminary examination of normal tissue and melanoma-derived DNA reveals that dierential methylation is an unlikely mechanism, and that the CDKN2X promoter/exon 1 region is distinctly hypomethylated in all tested tissues including melanoma (unpublished results). We are presently analysing CDKN2X in tumors for the presence of somatic mutations.
Sequence comparisons between the two species' CDKN2X 5'¯ank/putative promoter areas reveal numerous dierences including a 20 bp region absent in X. maculatus and an expanded GT-repeat microsatellite region that is much reduced in X. helleri. In addition, examination of heterozygous BC 1 hybrids reveals that the X. maculatus allele is expressed at signi®cantly higher levels than the X. helleri allele and this phenomenon seems to be greatly manifested in melanoma (Table 2) . It is hypothetically possible that the platy®sh (X. maculatus) allele is more capable of suppressing the proliferative eects of the Xmrk-2 tyrosine kinase receptor oncogene in the G1 checkpoint phase of the cell cycle due to higher response within cells of the melanocytic pathway. Thus, dierential expression of each species' CDKN2X alleles may result in the strong correlations of genotype and susceptibility to melanoma formation. Dierential regulation within melanocytes could by itself account for the dierences within hybrid progeny, conferring partial suppression of melanotic growth in F 1 and heterozygote backcross ®sh, while providing inadequate suppression in individuals acquiring two CDKN2X alleles from X. helleri. Since the sex-linked X. maculatus macromelanophore pigment patterns Sd and Sp do not exist in X. helleri, it is possible that CDKN2X from the former species has evolved coordinately to regulate cells that constitute these pigment patterns. An alternative hypothesis of CDKN2X involvement may revolve around the development and dierentiation of melanocytes within Xiphophorus embryos. Since BC 1 hybrid fry approximately 7 ± 10 days old display much larger numbers of melancotyes and macromelanophores than non-hybrid ®sh, it is distinctly possible that CDKN2X allelic dierences have already been functionally manifested. To address such an hypothesis and others we are currently initiating studies of p13 CDKN2X within embryos and assessment of immunohistochemical distribution within embryos, fry and adult histological sections.
The marked expression of CDKN2X in ®sh melanomas parallels the CDKN2A (P16) overexpression found in several neoplastic tissues including a subset of human malignant breast carcinomas (Emig et al., 1998) , cervical and genital lesions (Sano et al., 1998a,b) , ovarian carcinomas (Shigemasa et al., 1997) and mouse bladder carcinomas (Asamoto et al., 1998) . These reports, however, represent exceptional situations, as references describing lack of CDKN2A (P16) expression due to somatic deletion, mutation, or transcriptional repression by promoter cytosine methylation within many other cancers are much more numerous (see Ruas and Peters, 1998 for review) . While examination of CDKN2A (P16) within familial melanoma pedigrees and individuals developing sporadic melanomas has revealed similar phenomena of deletion, mutation, or transcriptional silencing, marked overexpression within melanoma cells is not typically observed (see Dracopoli and Fountain, 1996; Ruas and Peters, 1998 for review), in contrast to the ®sh CDKN2X expressional characteristics. This dierence may, however, simply be a consequence of the pronounced and consistent overexpression of the Xmrk-2 receptor tyrosine kinase in the ®sh model system. Hypothetically, CDKN2X would be attempting to regulate the G1 checkpoint; such a role is certainly parallel to that of mammalian tumor suppressor CDKN2A with human cancers, including melanoma, where alterations to critical genes involved in the G1 phase (such as cyclin D1, CDK4, and/or CDKN2A) have been noted (see Dracopoli and Fountain, 1996; Maelandsmo et al., 1996; Ruas and Peters, 1998 for review) .
In the Gordon-Kosswig melanoma model, overexpression of the Xmrk-2 gene is believed to be the oncogenic stimulus that leads to neoplastic transformation of pigment cells of the Sd pigment pattern. Xmrk-2 has been shown to be highly expressed in melanized tissues, with maximal expression being observed in melanoma (Schartl, 1995; Wittbrodt et al., 1989; Woolcock et al., 1994) and is believed to act as a mediator of proliferation in melanotic cells (Dimitrijevic et al., 1998; Wellbrock et al., 1998) . Here, we have analysed a similar melanoma model in which the melanomas are based on the Sp pigment pattern and have similarly detected gross Xmrk-2 overexpression in all melanized tissues including melanomas.
While eorts thus far have failed to reveal an ortholog of Xmrk-2 in humans, monoclonal antibodies raised against the extracellular domain exhibit sensitivity and speci®city towards human melanoma (Vielkind et al., 1993 (Vielkind et al., , 1997 . Another receptor tyrosine kinase locus, EGFR (HER-1) which shows marked sequence similarity with Xmrk-2 (Wittbrodt et al., 1989) , has been previously implicated in the formation of human melanoma (see Kraehn et al., 1995, for review) . Human EGFR has been mapped to chromosomal region 7p11-13 (Davies et al., 1980) , a region frequently rearranged in melanomas (Herlyn, 1990 ). Overexpression of EGFR was shown to be associated with spontaneous metastases of a human melanoma cell line in nude mice (Huang et al., 1996) , and expression of EGFR is related to speci®c stages of melanocytic cellular dierentiation and melanoma progression (de Wit et al., 1992; Real et al., 1986) . In addition, transgenic studies have shown that other overexpressed activated receptor tyrosine kinases can result in melanoma formation in mouse tumor models (Iwamoto et al., 1991 (Iwamoto et al., , 1992 Takayama et al., 1997) . Finally, another murine study showed that melanocytespeci®c transgenic expression of an activated HRAS oncogene strongly cooperated in a CDKN2A (P16) locus null background to generate melanomas with short latency and high penetrance (Chin et al., 1997) . These studies, as well as the numerous reports of CDKN2A (P16) involvement in human/rodent melanoma tumor suppression, and results presented regarding Xiphophorus melanomagenesis, collectively imply that the G1 phase of the cell cycle is very commonly abnormally regulated in melanocytic cells (see Dracopoli and Fountain, 1996; Maelandsmo et al., 1996; Ruas and Peters, 1998 for review) . Within the context of such data, further study of CDKN2X, Xmrk-2 and melanoma formation in Xiphophorus ®sh melanoma models is both relevant and merited.
Materials and methods
Animal strains and DNA extraction
Female X. maculatus (Jp 163 B) individuals carrying the Sp pigment pattern were arti®cially inseminated (Clark, 1950) with sperm collected from X. helleri (Rio Sarabia). F 1 hybrid males were then mated to X. helleri females to produce BC 1 hybrids. BC 1 ®sh were usually sacri®ced at 6 months of age unless accelerated melanoma development required earlier euthanasia. All parental and hybrid ®sh were obtained from the Xiphophorus Genetic Stock Center (Southwest Texas State University, San Marcos, TX, USA) or from the Science ParkResearch Division aquarium facilities (UTMD Anderson Cancer Center, Smithville, TX, USA). X. maculatus nucleic acids were derived from either Jp 163 A or Jp 163 B strains while X. helleri samples were derived from the Rio Sarabia strain. High MW DNA was extracted from pooled spleen, kidney and gill tissues with the aid of a Puregene kit (Gentra Systems, MN, USA).
Cloning and sequencing of CDKN2X
Using Touchdown-PCR (Don et al., 1991) with primers designed based on published CDKN2 gene family sequences, a 130 bp amplimer derived from the genome of X. maculatus was initially cloned and sequenced (Nairn et al., 1996b) . Oligonucleotide primers were then designed based on sequence information from this clone, for use in`Inverse' -PCR (Ochman et al., 1988) using X. helleri EcoRI-digested DNA. A 2870 bp amplimer was isolated and fully sequenced with sequentially designed oligonucleotide primers. Later, conventional PCR was performed to amplify the entire region from X. maculatus, as well as a clone from X. helleri to complete the sequencing of coding and promoter areas. In addition, two l phage CDKN2X clones were isolated from a genomic library of X. maculatus Jp 163 A (Stratagene, CA, USA), that were partially sequenced both to con®rm data derived from PCR ampli®cation and to provide sequence information in 5' and 3'¯anking areas. All cloning of PCR products was performed with the aid of a TA cloning kit (Invitrogen, CA, USA) following provided protocols, while DNA sequencing was performed with either a Circumvent kit (NEB, MA, USA) or a 33 P dideoxy terminator kit (Amersham, NJ, USA). Additional sequencing employing the dideoxy terminator sequencing kit (Amersham, NJ, USA) was performed using dITP to resolve gel compressions in selected areas. Figure 1 diagrammatically shows the positions and origin of all genomic clones involved in this study.
RNA extraction and allele-speci®c RT ± PCR
Total RNA was extracted with the aid of Trizol reagent (Gibco ± BRL, MD, USA). For allele-speci®c RT ± PCR, 1 mg of total RNA was used to create cDNA, employing a kit provided oligo(dT) primer and Superscript II (Gibco ± BRL, MD, USA). Two ml of the original 20 ml cDNA were used for subsequent PCR ampli®cation of a 374 bp amplimer using primers p16F17 (5'-atagtagggtacaacaggact-3') and p16R22 (5'-taattcacctttatgacagcct-3'). These primers are not speciesspeci®c, but are a perfect match to both X. helleri and X. maculatus. Ampli®cation parameters were as follows: (948C C/2'-1 cycle; 948C/1', 558C/1', 748C/1.5'-32 cycles, 748C/10'-1 cycle, 318C/10', 1 cycle), using an Omn-E thermal cycler (Hybaid, MA, USA). After PCR, DNA was precipitated by adding 1/10 volume 3 m NaAc (pH=5.2) and 2.5 volumes of absolute ethanol (7208C). After centrifugation and a wash with 75% ethanol, pellets were dried and resuspended in 17 ml dH 2 O. EcoRI digestion was performed by using 10 Units of enzyme (Gibco ± BRL, MD, USA) and 2 h incubations at 378C. DNAs were electrophoresed using 1.8% agarose gels, post-stained with ethidium bromide to 0.5 mg/ml, and visualized using a IF-500 Gel Documentation System (Alpha Innotech, CA, USA). Ratios of X. maculatus CDKN2X (unrestricted) to X. helleri (restricted) allelic products were determined with the aid of NIH Image computer software (version 1.62). X. helleri and X. maculatus samples were always used as controls, especially to ensure proper (complete restriction and without star activity) endonuclease digestion.
5' and 3' RACE methodology
To establish upstream CDKN2X transcript start sites, intron/ exon boundary, and the position of 3' polyadenylated regions, rapid ampli®cation of cDNA ends (RACE; Frohman et al., 1988) experiments were performed to complement genomic sequencing. 5' and 3' RACE kits were used, generally following the manufacturer's protocols (Gibco ± Characterization of a fish CDKN2 gene S Kazianis et al BRL, MD, USA). For 3' RACE, primer P16F4 (5'-ttacggacaaaagcaccg-3') was used in combination with kitprovided`AUAP' primer, followed by a single-nested PCR ampli®cation with primer P16F17 (5'-atagtagggtacaacaggact-3') and AUAP. For 5' RACE primers P16R18 (5'-tccaggacagcaacaacatccgt-3') or p16R6 in combination with kit-provided anchor primer were employed, followed by single-nested re-ampli®cation using P16R3 (5'-cgtcagtaagagccgag-3' for X. maculatus) or P16R4 (5'-cgagccacctccgagct-3' for X. helleri) and anchor primer. All cloning of PCR products and sequencing was performed as outlined above.
Xmrk competitive RT ± PCR assay RT ± PCR of Xmrk-1 and -2 transcripts was performed generally as described (Woolcock et al., 1994) with the following modi®cations. In most cases DNase I (Ampli®cation grade, Gibco ± BRL, MD, USA) treatment of RNA preceded cDNA synthesis following the manufacturer's protocol. Southern analyses were done using standard methods, using puri®ed Xmrk-2 product of PCR ampli®cation with mrkA (5'-gctgagctctgatgacgacg-3') and mrkB (5'-ggacaggagtgtacagtgcg-3') primers (Woolcock et al., 1994) that were radiolabeled with 32 P-dCTP as the probe. Quantitation of RT ± PCR products was done by phosphor screen autoradiography with the Storm 860 phosphoimager and ImageQuant software (Molecular Dynamics, CA, USA).
Relative RT ± PCR of CDKN2X CDKN2X RNA expression was quantitated in relationship to ampli®cation of 18S rRNA with the aid of a Quantum RNA RT ± PCR kit (Ambion, TX, USA). Initial experiments were conducted to ensure that PCR ampli®cation using a ®xed amount of RNA/cDNA as starting material would be within a linear range. We initially ampli®ed using 0.5, 5.0, 250, 500, 750 and 1000 ng of starting RNA and discovered that ampli®cation was linear between 250 ± 1000 ng RNA starting material, with a subsequent decision to use 500 ng of RNA in 20 ml volume. One ml of this cDNA was used for multiplex PCR with primers P16F16 (5'-tggaggatgaactgacgacagc-3') and P16R18 (5'-tccaggacagcaacaacatccgt-3') and kitprovided 18S rRNA primers (tcaagaacgaaagtcggagg-forward; ggacatctaagggcatcaca-reverse). Competimers (anti-sense 18S RNA oligonucleotides) were used at a ratio of 7 : 3 (competimer to primer). Thermal cycler parameters were identical to those outlined for the allele-speci®c CDKN2X assay, above. DNAs were electrophoresed using 1.8% agarose gels, post-stained with ethidium bromide to 0.5 mg/ ml, and visualized using a IF-500 Gel Documentation System (Alpha Innotech, CA, USA). Ratios of CDKN2X (358 bp) to 18S rRNA amplimers (488 bp) were determined with the aid of NIH Image computer software (version 1.62).
Computational methods
Nucleotide and aa sequence alignments were performed using the Clustal W computer program (version 1.6; Thompson et al., 1994) . Analysis of upstream DNA sequences was performed using MatInspector (0.80 core similarity/0.85 matrix similarity cut-o values; (Quandt et al., 1995) and MacVector (version 6.5, Eastman Kodak, NY, USA) software. The aa alignment was used to perform a bootstrapped (1000 replicate) parsimony analysis employing PAUP (version 3.1.1) and MacClade (version 3.05; Maddison and Maddison, 1992) . This same aa alignment was used to create a`Dayho-PAM' distance matrix (PHYLIP, version 3.572; Dayho and Orcutt, 1979; Felsenstein, 1989) .
